More than 1.2 million people – and potentially millions more – died in 2019 as a direct result of antibiotic-resistant bacterial infections, according to the most comprehensive estimate to date of the global impact of antimicrobial resistance (AMR). The analysis of 204 countries and territories, published in The Lancet, reveals that AMR is now a…
Study includes more than 2,700 healthcare workers in Delhi, India, who were symptomatic and underwent RT-PCR testing for COVID-19. Findings suggest 50% vaccine effectiveness against symptomatic COVID-19 after two doses of BBV152. This vaccine effectiveness is lower than the vaccine efficacy suggested by Bharat Biotech’s phase 3 randomised control trial results. The authors note several…
First global estimates of impact of the COVID-19 pandemic on mental health in 2020 suggests additional 53 million cases of major depressive disorder and 76 million cases of anxiety disorders were due to the pandemic. Women and younger people were the most affected by major depressive disorder and anxiety disorders in 2020. Countries hit hardest…
The fluvoxamine arm of the TOGETHER trial, a randomised adaptive platform trial investigating the efficacy of repurposed treatments for COVID-19 among high-risk Brazilian adult outpatients, is the largest trial of the SSRI fluvoxamine as a COVID-19 treatment to date. Of the 741 participants who were treated in an emergency setting for COVID-19 after receiving fluvoxamine,…
Study of 621 people in the UK with mild COVID-19 infections found that people who received two vaccine doses could still pass the infection on to vaccinated and unvaccinated household members. The analysis found that 25% of vaccinated household contacts tested positive for COVID-19 compared with 38% of unvaccinated household contacts. The infectiousness of vaccinated…
Uganda on 13 November received 1,904,140 doses of the Moderna COVID-19 vaccine, donated by the Canadian Government and shipped via the COVAX facility, —the world’s facility for universal access to COVID-19 vaccines. The arrival marks an important step towards the goal to ensure equitable distribution of COVID-19 vaccines globally. Uganda is targeting the vaccination of…
By World Health Organisation Africa is expected to experience the highest increase in diabetes globally. The number of people suffering from the disease is predicted to rise to 55 million by 2045—a 134% spike compared with 2021. At 70%, the continent also has the world’s highest number of people who do not know they have…
Africa’s sharp increase in diabetes is clashing with the COVID-19 pandemic and poor access to vaccines says the World Health Organsiation. Africa’s death rates from COVID-19 infections are significantly higher in patients with diabetes, according to a preliminary analysis which the World Health Organization (WHO) presented in advance of the World Diabetes Day on 14…
BY WHO Uganda Team Uganda launched the Third Edition of the National Guidelines for Integrated Diseases Surveillance and Response (IDSR) at Golden Tulip Hotel in Kampala. The third edition highlights new methods of disease detection, reporting, and provision of real-time surveillance data using new technologies and platforms. The platforms include event-based disease surveillance, community-based surveillance,…
Cote d’Ivoire has launched Ebola vaccination of high-risk populations, including health workers and first responders in Abidjan, where an Ebola outbreak was declared on 14 August. The country was able to swiftly begin the vaccination on 16 August with the rVSV-ZEBOV Ebola vaccine manufactured by Merck as the vaccine doses that the World Health Organization…